Clinical Trial Update: The Effect of a Probiotic on Hepatic Steatosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effect of a probiotic on hepatic steatosis (fatty liver) conducted by VSL Pharmaceuticals was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease

Drugs mentioned

• Probiotic formulation

Snippet

Sponsor: VSL Pharmaceuticals | Conditions: Fatty Liver | Phase 1 | Status: TERMINATED